Xenograft-based, platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastoma

Documenti analoghi

• Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
  di: Kitange, Gaspar J., et al.
  Pubblicazione: (2009)
• Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme
  di: Giannini, Caterina, et al.
  Pubblicazione: (2005)
• p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells
  di: Cen, Ling, et al.
  Pubblicazione: (2012)
• Heterogeneous Binding and Central Nervous System Distribution of the Multitargeted Kinase Inhibitor Ponatinib Restrict Orthotopic Efficacy in a Patient-Derived Xenograft Model of Glioblastoma
  di: Laramy, Janice K., et al.
  Pubblicazione: (2017)
• Establishment, Maintenance and in vitro and in vivo Applications of Primary Human Glioblastoma Multiforme (GBM) Xenograft Models for Translational Biology Studies and Drug Discovery
  di: Carlson, Brett L., et al.
  Pubblicazione: (2011)